Chemical Compound

(R)-3-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol

CAS Registry Number 53910-25-1
返回搜索 申请报价
(R)-3-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol 结构式
Primary record

(R)-3-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol

库存
5,847 克
纯度
98.6 %
CAS
53910-25-1

化合物标识与属性

CAS
53910-25-1
PubChem CID
439693
SMILES
C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O
Canonical SMILES
OC[C@H]1O[C@@H](n2cnc3c2NC=NC[C@H]3O)C[C@@H]1O

名称与同义词

  • pentostatin
  • Deoxycoformycin
  • Nipent
  • 2'-Deoxycoformycin
  • CO-Vidarabine
  • Pentostatina
  • Pentostatine
  • Vidarbine
  • Covidarabine
  • Pentostatinum
  • Coforin
  • Oncopent
  • 53910-25-1
  • 2'-Dexoycoformycin
  • PD-ADI
  • Co-V
  • Nipent (TN)
  • (R)-Deoxycoformycin
  • 2'-DCF
  • 2' Deoxycoformycin
  • Vira A deaminase inhibitor
  • Pentostatin (PTN)
  • (R)-2'-Deoxycoformycin
  • 8R-2'-Deoxycoformycin
  • CI-825
  • YK-176
  • 2 -Deoxycoformycin
  • Deaminase inhibitor (PD)
  • Pentostatin (Standard)
  • RefChem:57393
  • NSC-218321
  • Pentostatine [INN-French]
  • Pentostatinum [INN-Latin]
  • CI-825;Deoxycoformycin
  • PENTOSTATIN [MI]
  • Pentostatina [INN-Spanish]
  • PENTOSTATIN [INN]
  • PENTOSTATIN [JAN]
  • DTXSID2023436
  • PENTOSTATIN [HSDB]
  • PENTOSTATIN [USAN]
  • D0T3AD
  • 2 -Deoxy-D-coformycin
  • PENTOSTATIN [VANDF]
  • AC1L97UQ
  • Pentostatin (JAN/USAN/INN)
  • SCHEMBL2817
  • DTXCID403436
  • PD 81565
  • PD-81565
  • CHEMBL1580
  • PENTOSTATIN [MART.]
  • PENTOSTATIN [WHO-DD]
  • UNII-395575MZO7
  • HSDB 6547
  • BIDD:GT0136
  • FPVKHBSQESCIEP-JQCXWYLXSA-N
  • MFCD00078802
  • NSC218321
  • C11H16N4O4
  • GTPL4805
  • SCHEMBL1649740
  • 395575MZO7
  • NSC 218321
  • Pentostatin [USAN:INN:BAN:JAN]
  • BDBM22925
  • CHEBI:27834
  • HY-A0006R
  • Pentostatin, >=95% (HPLC)
  • L01XX08
  • PENTOSTATIN [ORANGE BOOK]
  • CI 825
  • BDBM223291
  • CI825
  • GLXC-05480
  • AMY10324
  • HY-A0006
  • Pentostatin [USAN:BAN:INN:JAN]
  • ZINC3806262
  • BRN 1223097
  • Tox21_113417
  • CID439693
  • EBC-08665
  • MSK164430
  • NCGC00182045-01
  • s9521
  • AKOS024456918
  • AKOS032949742
  • C11-H16-N4-O4
  • CL 67310465
  • CL-67310465
  • AD03945
  • CS-0374
  • DB00552
  • RL03997
  • NCGC00388420-02
  • Deaminase, inhibitor for adenosine arabinoside
  • J10.843J
  • AB0010579
  • CAS-53910-25-1
  • A3708
  • NS00005086
  • C02267
  • D00155
  • EN300-222177
  • Q-4464
  • dCF
  • 910P251
  • A829822
  • Q425470
  • SR-01000883935
  • (8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
  • SR-01000883935-1
  • BRD-K91543828-001-02-0
  • (8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
  • (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol
  • (R)-3-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
  • Adenosine Deaminase Inhibitor, DCF - CAS 53910-25-1
  • Z2204459563
  • (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol
  • (R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol
  • (R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol
  • (8R)-3-(2-Deoxy-?-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
  • (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol
  • Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-
  • Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-
  • (8R)-3,4,7,8-Tetrahydro-3-(2-deoxy-beta-D-erythro-pentofuranosyl)imidazo[4,5-d][1,3]diazepine-8-ol
  • (8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H,4H,7H,8H-imidazo(4,5-d)(1,3)diazepin-8-ol
  • (8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H,6H,7H,8H-imidazo(4,5-d)(1,3)diazepin-8-ol
  • (8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-7,8-dihydro-4H-imidazo(4,5-d)(1,3)diazepin-8-ol
  • (8R)-3-(2-Deoxy-b-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
  • (8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]-diazepin-8-ol
  • (8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8beta-ol
  • (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol
  • (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-8-ol
  • (R)-3-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
  • (R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
  • 63677-95-2
  • 637-271-5
  • Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-
  • Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-
  • Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-
  • Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-
  • Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-b-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-
  • N/A